Viability study of a multiplex diagnostic platform for Chagas disease

A new multiplex assay platform was evaluated to detect Trypanosoma cruzi infection using the recombinant antigens CRA, FRA, CRAFRA fusion and parasite lysate. The antigens presented different sensitivity and specificity in a singleplex test when compared to a serial dilution of two pools comprising...

Full description

Bibliographic Details
Main Authors: Leonardo Foti, Bruna de Paula Fonseca e Fonseca, Lilian Dias Nascimento, Christiane de Fatima Silva Marques, Edmilson Domingos da Silva, Cesar Augusto Barros Duarte, Christian M Probst, Samuel Goldenberg, Antônio Gomes Pinto, Marco Aurélio Krieger
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2009-07-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000900019
_version_ 1797757707734745088
author Leonardo Foti
Bruna de Paula Fonseca e Fonseca
Lilian Dias Nascimento
Christiane de Fatima Silva Marques
Edmilson Domingos da Silva
Cesar Augusto Barros Duarte
Christian M Probst
Samuel Goldenberg
Antônio Gomes Pinto
Marco Aurélio Krieger
author_facet Leonardo Foti
Bruna de Paula Fonseca e Fonseca
Lilian Dias Nascimento
Christiane de Fatima Silva Marques
Edmilson Domingos da Silva
Cesar Augusto Barros Duarte
Christian M Probst
Samuel Goldenberg
Antônio Gomes Pinto
Marco Aurélio Krieger
author_sort Leonardo Foti
collection DOAJ
description A new multiplex assay platform was evaluated to detect Trypanosoma cruzi infection using the recombinant antigens CRA, FRA, CRAFRA fusion and parasite lysate. The antigens presented different sensitivity and specificity in a singleplex test when compared to a serial dilution of two pools comprising 10 positive serum samples and one pool of 10 negative samples. The recombinant protein CRA presented lower sensitivity (55%) in contrast to the 100% specificity and sensitivity of FRA, CRAFRA and T. cruzi lysate. These antigens also showed good results in a duplex test and the duplex test with CRAFRA/T. cruzi lysate showed better performance with 100% specificity and sensitivity, as well as a lower cut-off value in comparison to the other duplex test, FRA/T. cruzi lysate. Hence, when the antigens were used in duplex format, both tests showed decreased cut-off values and no interference between different bead sets, resulting in increasing sensitivity and specificity. The results of these multiplex tests show that they could be an alternative to singleplex detection for Chagas disease, and also indicate the necessity of using multiplex diagnostic tools to increase the sensitivity and specificity for diagnostic tests. Emerging data from the T. cruzi genome and from its ORFeome project will also allow the identification of new antigens for this disease detection application.
first_indexed 2024-03-12T18:19:25Z
format Article
id doaj.art-9d16277f07e14299846ab01be3a2d566
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:19:25Z
publishDate 2009-07-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-9d16277f07e14299846ab01be3a2d5662023-08-02T09:00:00ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602009-07-0110413614110.1590/S0074-02762009000900019Viability study of a multiplex diagnostic platform for Chagas diseaseLeonardo FotiBruna de Paula Fonseca e FonsecaLilian Dias NascimentoChristiane de Fatima Silva MarquesEdmilson Domingos da SilvaCesar Augusto Barros DuarteChristian M ProbstSamuel GoldenbergAntônio Gomes PintoMarco Aurélio KriegerA new multiplex assay platform was evaluated to detect Trypanosoma cruzi infection using the recombinant antigens CRA, FRA, CRAFRA fusion and parasite lysate. The antigens presented different sensitivity and specificity in a singleplex test when compared to a serial dilution of two pools comprising 10 positive serum samples and one pool of 10 negative samples. The recombinant protein CRA presented lower sensitivity (55%) in contrast to the 100% specificity and sensitivity of FRA, CRAFRA and T. cruzi lysate. These antigens also showed good results in a duplex test and the duplex test with CRAFRA/T. cruzi lysate showed better performance with 100% specificity and sensitivity, as well as a lower cut-off value in comparison to the other duplex test, FRA/T. cruzi lysate. Hence, when the antigens were used in duplex format, both tests showed decreased cut-off values and no interference between different bead sets, resulting in increasing sensitivity and specificity. The results of these multiplex tests show that they could be an alternative to singleplex detection for Chagas disease, and also indicate the necessity of using multiplex diagnostic tools to increase the sensitivity and specificity for diagnostic tests. Emerging data from the T. cruzi genome and from its ORFeome project will also allow the identification of new antigens for this disease detection application.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000900019Chagas diseasediagnosticmultiplexbead-based assayTrypanosoma cruzi
spellingShingle Leonardo Foti
Bruna de Paula Fonseca e Fonseca
Lilian Dias Nascimento
Christiane de Fatima Silva Marques
Edmilson Domingos da Silva
Cesar Augusto Barros Duarte
Christian M Probst
Samuel Goldenberg
Antônio Gomes Pinto
Marco Aurélio Krieger
Viability study of a multiplex diagnostic platform for Chagas disease
Memorias do Instituto Oswaldo Cruz
Chagas disease
diagnostic
multiplex
bead-based assay
Trypanosoma cruzi
title Viability study of a multiplex diagnostic platform for Chagas disease
title_full Viability study of a multiplex diagnostic platform for Chagas disease
title_fullStr Viability study of a multiplex diagnostic platform for Chagas disease
title_full_unstemmed Viability study of a multiplex diagnostic platform for Chagas disease
title_short Viability study of a multiplex diagnostic platform for Chagas disease
title_sort viability study of a multiplex diagnostic platform for chagas disease
topic Chagas disease
diagnostic
multiplex
bead-based assay
Trypanosoma cruzi
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000900019
work_keys_str_mv AT leonardofoti viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT brunadepaulafonsecaefonseca viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT liliandiasnascimento viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT christianedefatimasilvamarques viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT edmilsondomingosdasilva viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT cesaraugustobarrosduarte viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT christianmprobst viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT samuelgoldenberg viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT antoniogomespinto viabilitystudyofamultiplexdiagnosticplatformforchagasdisease
AT marcoaureliokrieger viabilitystudyofamultiplexdiagnosticplatformforchagasdisease